25
Participants
Start Date
February 28, 2003
Primary Completion Date
February 29, 2008
Study Completion Date
March 31, 2013
filgrastim
cisplatin
cyclophosphamide
cytarabine
dexrazoxane hydrochloride
doxorubicin hydrochloride
etoposide
leucovorin calcium
methotrexate
temozolomide
therapeutic hydrocortisone
vincristine sulfate
radiation therapy
Dactinomycin
Children's Hospital of Philadelphia, Philadelphia
AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Scottish Rite Campus, Atlanta
Cleveland Clinic Taussig Cancer Center, Cleveland
Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis
Children's Memorial Hospital - Chicago, Chicago
Simmons Comprehensive Cancer Center at University of Texas Southwestern Medical Center - Dallas, Dallas
Sunrise Hospital and Medical Center, Las Vegas
Stanford Cancer Center, Stanford
Yale Cancer Center, New Haven
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore
Children's Hospital Boston, Boston
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute, Boston
National Cancer Institute (NCI)
NIH
Dana-Farber Cancer Institute
OTHER